Bile duct inflammation and scarring, known as cholangiopathies, can disrupt bile flow, leading to liver damage and ...

Sclerosing cholangitis and primary biliary cirrhosis, which is now called primary biliary cholangitis (PBC), are chronic cholestatic liver diseases, but they differ in their causes, affected bile ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

Nebokitug has received FDA and EMA Orphan Drug status and FDA Fast Track designation for the treatment of primary sclerosing cholangitis in adults. Disclaimer: This is an AI-generated summary of a ...

A research team from the Medical University of Vienna has made further progress in the treatment of intestinal inflammation.

The clinical picture of SSC resembles that of primary sclerosing cholangitis (PSC), with the presence of progressive hepatic fibrosis, multiple irregular biliary strictures and biliary dilatations.

A research team has made further progress in the treatment of intestinal inflammation. A study shows that the semi-synthetic bile acid NorUDCA inhibits in the intestine the formation of ...

H.C. Wainwright raised the firm’s price target on ProQR Therapeutics (PRQR) to $12 from $10 and keeps a Buy rating on the shares. The firm says ...